Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...

Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.

Elevance Health (ELV) stock rises as CFO cites underestimated Q1 profit forecasts from analysts for the company at Barclays ...

Shares of Elevance Health Inc. ELV shed 2.61% to $411.04 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.49% to 5,599.30 ...

In a regulatory filing, Elevance Health (ELV) disclosed that its officers will speak with investors over the next several weeks. During these ...

Elevance Health (ELV) shares soared 3.1% in the last trading session to close at $422.04. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

Investors in Elevance Health Inc (Symbol: ELV) saw new options become available today, for the May 16th expiration. One of the key data points that goes into the price an option buyer is willing ...

We came across a bullish thesis on Elevance Health, Inc. (NYSE:ELV) on ValueInvestorsClub by rhubarb. In this article, we ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Elevance Health jumped 3.1% in the last session, extending its six-day rally. The surge was fueled by investor optimism, a ...